AU2742395A - Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets - Google Patents

Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets

Info

Publication number
AU2742395A
AU2742395A AU27423/95A AU2742395A AU2742395A AU 2742395 A AU2742395 A AU 2742395A AU 27423/95 A AU27423/95 A AU 27423/95A AU 2742395 A AU2742395 A AU 2742395A AU 2742395 A AU2742395 A AU 2742395A
Authority
AU
Australia
Prior art keywords
pets
therapeutic
administration
dietetic composition
medicinal gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27423/95A
Inventor
Marie-Sophie Francoise Danielle Filhol
Jerome Guyonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Elf Sanofi SA
Sanofi Sante Nutrition Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elf Sanofi SA, Sanofi Sante Nutrition Animale filed Critical Elf Sanofi SA
Publication of AU2742395A publication Critical patent/AU2742395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
AU27423/95A 1994-06-09 1995-06-07 Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets Abandoned AU2742395A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9407074A FR2720944B1 (en) 1994-06-09 1994-06-09 Therapeutic or dietetic composition in the form of a medicated gel for administration to pets.
FR9407074 1994-06-09
PCT/FR1995/000745 WO1995033444A1 (en) 1994-06-09 1995-06-07 Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets

Publications (1)

Publication Number Publication Date
AU2742395A true AU2742395A (en) 1996-01-04

Family

ID=9464048

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27423/95A Abandoned AU2742395A (en) 1994-06-09 1995-06-07 Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets

Country Status (4)

Country Link
EP (1) EP0765156A1 (en)
AU (1) AU2742395A (en)
FR (1) FR2720944B1 (en)
WO (1) WO1995033444A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5453198A (en) * 1996-11-29 1998-06-22 Monsanto Company Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients
FR2796248B1 (en) * 1999-07-12 2003-04-04 Skw Biosystems NON-AERATED GEL CONFECTIONERY BASED ON CARRAGHENANE
EP1136067A1 (en) * 2000-03-23 2001-09-26 Pfizer Limited Oral formulations of medicaments
FR2808970B1 (en) * 2000-05-19 2003-01-31 Royal Canin Sa FOOD SLOWING DOWN DOG INGESTION SPEED
US20030003059A1 (en) * 2001-04-03 2003-01-02 Frederic Dana Dentifrice compositions
FR2879076B1 (en) * 2004-12-15 2007-09-21 Royal Canin Sa DOG FEED OF THE BRACHYCEPHALE TYPE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2122892B (en) * 1982-07-02 1986-01-29 Squibb & Sons Inc Nystantin pastille formulation
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof

Also Published As

Publication number Publication date
FR2720944A1 (en) 1995-12-15
EP0765156A1 (en) 1997-04-02
WO1995033444A1 (en) 1995-12-14
FR2720944B1 (en) 1996-09-06

Similar Documents

Publication Publication Date Title
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
AU5745290A (en) Improvements in or relating to medical ventilators
PL312064A1 (en) Soft gelatinous form of pharmaceutical dose
ZA899176B (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment
HUP9601161A2 (en) Use of retinoids in cosmetic compositions or for the manufacture of pharmaceutical compositions
AU1937395A (en) Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic
AU1299292A (en) Methods and substances for recruiting therapeutic agents to solid tissues
PL320916A1 (en) Derivatives of piperasino 2,5-dione as modulators of drug-fastness in respect to amny drugs
HUP9904027A3 (en) Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
AU2672795A (en) Benzopyrans and their use as therapeutic agents
AU8316587A (en) Pharmaceutical compositions and their use
AU1990592A (en) Skin and hair-care gel compositions
AU4633893A (en) Liposomal formulations for administering to cancer patients
GB2281863B (en) Improvements in relation to medical diathermy
AU2742395A (en) Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets
AU2587195A (en) Growth hormone therapy and related methods and pharmaceutical compositions
AU1727297A (en) Application of pyrrolidine derivatives to the preparation of medicaments intended to the treatment of drug abuse
AU7793791A (en) Pharmaceutical composition for use in treating pain
HUP9901659A3 (en) Use of flupirtin for producing pharmaceutical compositions suitable for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system
ZA967319B (en) Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
AU5252090A (en) Improvements in and relating to pharmaceutical formulations
AU3255295A (en) Hybrid molecules useful in the treatment of tumors, their preparation and use in pharmaceutical compositions
GB9401745D0 (en) Improvements in and relating to the administration of medicaments or therapeutic substances
AU1727397A (en) Application of pyrrolidine derivatives to the preparation of medicaments for the treatment of drug abuse